Other Comparison

Ovagen vs Thymalin

Comparison of Ovagen (Low evidence) and Thymalin (Moderate evidence).

Last updated: February 12, 2026

Ovagen

Low Evidence
View full dossier

Thymalin

Moderate Evidence
View full dossier

Overview

Ovagen and Thymalin are both studied in the peptide research space.

Ovagen: A synthetic tripeptide (Glu-Asp-Leu) developed by Russian scientist Vladimir Khavinson for liver support.

Thymalin: A thymic peptide complex developed in Russia and used clinically in the former Soviet Union for immunomodulation.

Evidence Comparison

AspectOvagenThymalin
Evidence LevelLowModerate
Human Studies18
Preclinical Studies822
Total Sources1030

Key Differences

AspectOvagenThymalin
CategoryOtherImmune
Evidence StrengthLowModerate
Total Sources1030
Human Studies18

Summary

  • Ovagen: Low evidence with 10 total sources (1 human)
  • Thymalin: Moderate evidence with 30 total sources (8 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.